Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0000950170-24-064235

Options or other derivatives

  • Director acquired 24,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
CLARKE JOHN K Director 2024-05-22 Grant or award · Stock Option (right to buy) +24,000 24,000 D: show line 1 in the form
Loading xslF345X05/ownership.xml…